To determine the in vivo relevance of the secretion of CD81+CD63+EVs, we injected two 67NR-S and one 67NR-NS cell line into the mammary fat pad of BALB/c mice and monitored the tumor growth for six weeks (Figure 4D). This evidence concerns the gene CD63 and neoplasm.